Evidence map›Paper›PMID 41158982›Full record

ReviewDrug design, development and therapy2025

Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms.

Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Pharmacodynamic material basis investigations of the crude and processed Radix et Rhizoma Rhei by the immobilized βMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Curcumin in Fibrosis Treatment: A Review.Drug design, development and therapy · 2026
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hua MiaoSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Kai-En WangSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Ping LiBeijing Key Laboratory for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Beijing, People's Republic of China.
Ying-Yong ZhaoSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.ORCID 0000-0002-0239-7342

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicines (TCMs) are practiced in clinical and healthcare settings and are widely employed as essential therapies for intervening diverse refractory illnesses. Rhubarb, which is prescribed as the root and rhizome of

Indexed as

Drugs, Chinese HerbalPhytochemicalsRheumAnimalsHumansMedicine, Chinese TraditionalMultiomicsDrugs, Chinese HerbalPhytochemicalsanticanceranticardiovascular diseasecardio-renoprotective effectgut microbiotahepatotoxicity and nephrotoxicitylong non-coding RNAsmetabolomerenoprotective activityrhubarb

Identifiers

PMID41158982
PMCPMC12558105

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.